Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00170820 |
The purpose of this study is to assess if a combination of everolimus, steroids, and mycophenolate mofetil is associated with a better renal function than sirolimus.
Condition | Intervention | Phase |
---|---|---|
Renal Transplantation |
Drug: Everolimus |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Single Arm, Prospective, Open-Label, Pilot Study to Assess Effects of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen |
Estimated Enrollment: | 20 |
Study Start Date: | February 2005 |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria
Study ID Numbers: | CRAD001AFR04 |
Study First Received: | September 9, 2005 |
Last Updated: | February 6, 2007 |
ClinicalTrials.gov Identifier: | NCT00170820 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Renal transplantation, maintenance, switch, everolimus, CNI-free |
Everolimus Sirolimus |
Immunologic Factors Physiological Effects of Drugs Immunosuppressive Agents Pharmacologic Actions |